It is the lead drug candidate for Opko, a Miami start-up company run by Phillip Frost, the billionaire who founded the generic drug company Ivax.

它是Opko候选的主打药物。Opko是一家迈阿密公司，由建立了基因药物公司Ivax的亿万富翁Phillip Frost经营。

youdao

Ivax Chief Executive Phillip Frost and other management shareholders have pledged the 19% of Ivax shares they own to the acquisition.

FORBES: Teva Takes On Novartis

As mentioned in my previous article, the lead investor in this offering was billionaire pharmaceutical investor Dr. Phillip Frost, the current chairman of Israeli drug giant Teva Pharmaceuticals.

FORBES: Blast Off Time For MusclePharm: $12 Million Offer is Complete

New pledge signatories announced today include Joyce and Bill Cummings, Ray and Barbara Dalio, John Paul DeJoria, Phillip and Patricia Frost, Harold and Sue Ann Hamm, Vinod and Neeru Khosla, Rich and Nancy Kinder, Edward W. and Deedie Potter Rose, Lynn Schusterman, and Annette and Harold Simmons.

FORBES: Ten More Tycoons Sign Buffett And Gates Giving Pledge: Dalio, Kinder, DeJoria